Remission in chronic rhinosinusitis with nasal polyps

Remission has recently been proposed as the new goal of care in CRSwNP or Nasal Polyp Syndrome by the European Forum for Research and Education in Allergy and Airway Diseases / European Position Paper on Rhinosinusitis and Nasal Polyps (EUFOREA/EPOS) (1,2) as well as by global leaders in Rhinology (3). In CRSwNP, remission is defined as a prolonged state of control, without bothersome symptoms reported by the patient for at least 12 months, without the need for either oral corticosteroids or endoscopic sinus surgery (ESS), and without endoscopic signs of active disease (1). This new goal of care is to be encouraged by the ENT community and CRSwNP patients as persistent symptoms unalleviated by historical approaches (4,5) can be reduced by new therapies including biologics. The goal of therapy for CRSwNP has long been to achieve control, with Visual Analogue Scale (VAS) and Sino-Nasal Outcome Test (SNOT-22) scores guiding physicians towards a step-up treatment aiming for control (6,7).

Authors

Institutions

Publication Details

Journal
Rhinology Journal
Published
2025-03-01
DOI
https://doi.org/10.4193/rhin24.457
Citations
6
Primary Topic
Sinusitis and nasal conditions
Type
article
Field-Weighted Citation Impact
11.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Remission in chronic rhinosinusitis with nasal polyps

Manuel Bernal‐Sprekelsen, Sven Schneider, Marjolein Cornet, Peter W. Hellings et al.
6 citations
Rhinology Journal
Sinusitis and nasal conditions
11.09
article

Remission in chronic rhinosinusitis with nasal polyps

Manuel Bernal‐Sprekelsen, Sven Schneider, Marjolein Cornet, Peter W. Hellings, Basile N. Landis, Stephanie J. Lee, Yi Tao Chan, Eugenio De Corso, J Han, Susanne Lau, Diego M. Conti, Brent A. Senior, Claire Hopkins, Philippe Gevaert, Vibeke Backer, J Mullol, W. J. Fokkens, V J Lund, Albert J. Peters
article en
6 citations

Abstract

Remission has recently been proposed as the new goal of care in CRSwNP or Nasal Polyp Syndrome by the European Forum for Research and Education in Allergy and Airway Diseases / European Position Paper on Rhinosinusitis and Nasal Polyps (EUFOREA/EPOS) (1,2) as well as by global leaders in Rhinology (3). In CRSwNP, remission is defined as a prolonged state of control, without bothersome symptoms reported by the patient for at least 12 months, without the need for either oral corticosteroids or endoscopic sinus surgery (ESS), and without endoscopic signs of active disease (1). This new goal of care is to be encouraged by the ENT community and CRSwNP patients as persistent symptoms unalleviated by historical approaches (4,5) can be reduced by new therapies including biologics. The goal of therapy for CRSwNP has long been to achieve control, with Visual Analogue Scale (VAS) and Sino-Nasal Outcome Test (SNOT-22) scores guiding physicians towards a step-up treatment aiming for control (6,7).

Rhinology JournalVol. 0(0)
Northwestern University (US), University of North Carolina at Chapel Hill (US), St Thomas' Hospital (GB), Johns Hopkins University (US), Eastern Virginia Medical School (US), University of Toronto (CA), Guy's and St Thomas' NHS Foundation Trust (GB), Agostino Gemelli University Polyclinic (IT), Copenhagen University Hospital (DK), Rigshospitalet (DK), Ghent University (BE), Centro de Investigación en Red en Enfermedades Cardiovasculares (ES), Alrijne Ziekenhuis (NL), University Hospital of Geneva (CH), Hospital Clínic de Barcelona (ES), Royal National Throat Nose and Ear Hospital (GB), Institute of Criminology (SI), Amsterdam University Medical Centers (NL), Eastman Dental Hospital (GB), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), University College London (GB), Universidad Autónoma de Madrid (ES), Universitat de Barcelona (ES), Medical University of Vienna (AT), Charité - Universitätsmedizin Berlin (DE), University of Amsterdam (NL), KU Leuven (BE)
Openalex Percentile: Top 1%
Sinusitis and nasal conditions
11.09
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.